Biotech Business - October 29, 2021
Abera enters collaboration with American university
Abera Bioscience initiates collaboration with an American university to accelerate the development of a vaccine candidate based on the company’s latest vaccine platform comprising protein bodies. The study will be conducted in vivo and will provide a first indication of applicability outside of the pneumococcal area. The cost profile for protein body-based vaccine formulations is […]
Collaboration - October 26, 2021
Read our current issue!
Our latest issue, No 04 2021, is out – sign up for a subscription today and stay updated on the Nordic life science industry’s latest progress and challenges. Real-World Evidence has taken a leap forward during the pandemic. Read more about the potential of RWE in drug development, and how we can better enable Nordic health […]
Collaboration - October 25, 2021
BIO-Europe 2021 has begun!
This event will offer a week of biotech, pharma and finance, including several very interesting on demand sessions. The digital event, October 25-28, will include one-to-one meetings, company presentations, company showcases and interesting keynotes and panels. Global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic […]
Collaboration - October 20, 2021
BioLamina with partners receive funding of 40 million SEK
BioLamina with partners in the innovation milieu IndiCell receive funding to establish and propel individualized cell therapy treatments in Sweden. The funded project focuses on an autologous therapy model, in which skin cells are harvested from the patients themselves, then carefully reprogrammed into induced pluripotent stem (iPS) cells in the laboratory, and finally returned to […]
Collaboration - October 15, 2021
Are you ready for BIO-Europe Digital?
This event will offer a week of biotech, pharma and finance, including several very interesting on demand sessions. The digital event, October 25-28, will include one-to-one meetings, company presentations, company showcases and interesting keynotes and panels. Global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic […]
Agreement - September 22, 2021
Ascelia Pharma signs clinical collaboration agreement
Ascelia Pharma has signed an agreement with Taiho Oncology, a subsidiary of Taiho Pharmaceutical. The collaboration concerns an upcoming global Phase 2 clinical study in gastric cancer. In this all-oral combination study, Ascelia Pharma’s irinotecan chemotherapy tablet Oncoral (ASC-201) will be evaluated in combination with Taiho Oncology’s LONSURF (trifluridine and tipiracil) film-coated tablets for oral […]
